Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Acta Poloniae Pharmaceutica - Drug Research is Scopus-indexed (Q4, CiteScore 0.8), WoS SCIE, DOAJ. Published by Polish Pharmaceutical Society.
Checked against the index lists dated .
ISSN 0001-6837Verify ISSN ↗2353-5288Verify ISSN ↗
Publisher: Polish Pharmaceutical Society
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 147 / 191 | 23rd | Q4 |
| Pharmacology | 277 / 328 | 15th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1961–2025 (also 1951–1955), best quartile Q4, CiteScore 0.8.
Acta Poloniae Pharmaceutica - Drug Research is Q4 in Pharmaceutical Science (rank 147 of 191) and Q4 in Pharmacology (rank 277 of 328), by CiteScore 2025.
Acta Poloniae Pharmaceutica - Drug Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.8, which places it in quartile Q4 at the 23rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.186, quartile Q3, with an H-index of 55.
Acta Poloniae Pharmaceutica - Drug Research is published by Polish Pharmaceutical Society. Its print ISSN is 0001-6837 and its online ISSN is 2353-5288.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Acta Poloniae Pharmaceutica - Drug Research has an h-index of 13 and a 2-year mean of 0.4 citations per paper (OpenAlex). Its Scopus CiteScore is 0.8, quartile Q4. On 2-year citations it ranks #140 of 177 Scopus journals in Pharmaceutical Science.
Acta Poloniae Pharmaceutica - Drug Research published 84 papers in 2025; its busiest recent year was 2019 with 114. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from China (45.4%), Poland (35.7%) and Czechia (2.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.